Urinary titanium and vanadium and breast cancer: a case-control study.

Area of Science:

• Environmental Health
• Oncology
• Nutritional Science

Background:

• Trace elements like titanium and vanadium play roles in biological processes.
• Understanding their association with cancer risk is crucial for public health.
• Previous research on vanadium and titanium in relation to breast cancer is limited.

Purpose of the Study:

• To investigate the association between urinary titanium and vanadium concentrations and the risk of breast cancer.
• To explore potential roles of these trace elements in breast cancer development or prevention.

Main Methods:

• A hospital-based case-control study was conducted with 240 breast cancer patients and 246 controls.
• Urinary concentrations of titanium and vanadium were measured using inductively coupled plasma mass spectrometry.
• Data on established breast cancer risk factors were collected via surveys.

Main Results:

• Women in the second and highest tertiles of urinary vanadium had a significantly decreased risk of breast cancer (ORs: 0.36 [0.21-0.60] and 0.60 [0.37-0.97], respectively).
• Urinary titanium concentrations were not significantly associated with breast cancer risk.
• These findings suggest a potential protective role for vanadium.

Conclusions:

• Elevated urinary vanadium levels may be associated with a reduced risk of breast cancer.
• Urinary titanium does not appear to be significantly linked to breast cancer risk.
• Further studies are needed to confirm these findings and elucidate the underlying biological mechanisms.